SCEVADIL*SUN CUT1FL60ML50MG/ML

SCEVADIL, 50 mg/ml, cutaneous solution
Minoxidil

What it is and what it is used for
SCEVADIL is a cutaneous solution containing the active ingredient minoxidil for the symptomatic treatment of androgenetic hair loss in men aged 18 to 55 years.

In men, SCEVADIL stabilises the course of androgenetic hair loss (androgenetic alopecia) in the vertex area of the scalp. The treatment is therefore able to counteract the progression of androgenetic hair loss.

The mechanism of action through which minoxidil and/or its metabolite stimulates hair growth is not yet clear. However, minoxidil is thought to act on hair follicles, increasing blood flow to the scalp through local vasodilation.
The onset and extent of this effect may vary from person to person and cannot be predicted.

SCEVADIL is for external use only and should only be applied to the scalp.

What you need to know before taking the medicine
Do not use SCEVADIL
- if you are allergic to minoxidil or any of the other ingredients of this medicine (listed in section 6);
- if you are a woman, as cosmetically traumatic, reversible signs of facial hair growth may occur during treatment;
- if you are using any other medicine on your scalp;
- if you use any type of dressing or bandage on your scalp;
- if you suffer from sudden or irregular hair loss;
- if you have any condition affecting the scalp, including psoriasis (a skin disease with inflammation and itching), sunburn, shaved scalp or if the skin of your scalp is damaged by scars or burns, as no hair follicles are present;
- if you have signs of cardiovascular disease or heart rhythm problems such as coronary heart disease, arrhythmias, congestive heart failure or valvular heart disease;
- if you have high blood pressure (arterial hypertension);
- if you are taking medicines to treat high blood pressure.

Warnings and precautions
Apply SCEVADIL to normal, healthy scalp. Do not use SCEVADIL if the cause of hair loss is unknown or if the scalp is red, inflamed or sore.

There is no clinical experience to date on the efficacy in hair loss in the temporal region (receding hairline).

SCEVADIL is for external use only on the scalp. Do not apply to other parts of the body.

Take particular care if you have or have had cardiovascular disease or a heart arrhythmia such as tachycardia, chest pain, loss of consciousness, dizziness, unexplained weight loss or signs of fluid and sodium retention (swelling of hands or feet). In such conditions, you should not use this medicine (see section Do not use SCEVADIL).

Patients with low blood pressure should contact their doctor before using topical minoxidil and should be monitored at the start of treatment and thereafter at regular intervals.

You should stop using SCEVADIL and consult your doctor if:
- you are found to have low blood pressure;
- you have high blood pressure;
- you are taking medicines to treat high blood pressure;
- if one or more of the following symptoms appear: chest pain, faster heartbeat, weakness or dizziness, sudden and unexplained weight loss, swelling of hands or feet, persistent redness or irritation of the scalp or if new unexpected symptoms appear (see section If you use more SCEVADIL than you should).

Transfer of the product to areas other than the scalp may cause unwanted hair growth.

Isolated cases of slight changes in hair colour have been reported by patients with very light hair in conjunction with the use of hair care products or after swimming in water with high chlorine content.

Accidental ingestion can cause severe cardiovascular adverse reactions. Therefore, keep this medicine out of the reach of children.

Avoid inhaling the nebulized spray.

As SCEVADIL contains alcohol and propylene glycol, it may cause a burning sensation and/or irritation if it accidentally comes into contact with sensitive areas (eyes, mucous membranes, abraded skin). In these cases, the affected area should be rinsed with plenty of running water. If the burning sensation and/or irritation persists, seek medical attention.

Children and adolescents
Do not apply SCEVADIL to children and adolescents under 18 years of age, as safety and efficacy in this age group have not been established.

Possible side effects
Like all medicines, SCEVADIL can cause side effects, although not everybody gets them.

Contact your doctor as soon as possible if you experience any of the following side effects - you may need urgent medical treatment.
- swelling of the face, lips or throat which may make swallowing or breathing difficult. This may be a sign of a severe allergic reaction (frequency not known, cannot be estimated from the available data)
- generalized skin redness (frequency not known, cannot be estimated from the available data)
- generalized itching (frequency not known, cannot be estimated from the available data)
- tightening of the throat (frequency not known, cannot be estimated from the available data)

Very common (may affect more than 1 in 10 people):
- Headache.

Common (may affect up to 1 in 10 people):
- Itching;
- Increased hair growth beyond the scalp (including facial hair growth in women), inflammatory skin reaction (including acneiform eruption, rash);
- Shortness of breath, breathing difficulties;
- Swollen legs and arms;
- Weight gain;
- High blood pressure;
- Scalp irritation with stinging, burning, itching, dryness, scaling and folliculitis.

Uncommon (may affect up to 1 in 100 people):
- Dizziness, nausea.

Not known (frequency cannot be estimated from the available data):
- Allergic dermatitis (skin inflammation related to an allergy);
- Depressed mood;
- Eye irritation;
- Rapid heartbeat, palpitations, low blood pressure;
- Vomiting;
- Symptoms at the administration site that may also affect the ears and face, such as itching, skin irritation, pain, redness, swelling, dry skin and inflammatory rash up to possible skin flaking, skin inflammation (dermatitis), blistering, bleeding and skin ulceration;
- Temporary hair loss, hair colour changes, altered hair texture;
- Chest pain.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.